Systemic organ wasting induced by localized expression of the secreted insulin/IGF antagonist ImpL2

Young Kwon1, Wei Song1, Ilia A Droujinine1

  • 1Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

Developmental Cell
|April 9, 2015
PubMed

Insights

Overproliferation in Drosophila gut stem cells causes organ wasting by increasing insulin/IGF antagonist ImpL2. The gut adapts by upregulating glycolysis and insulin/IGF pathway components to evade ImpL2 effects.

Area of Science:

  • Cell Biology
  • Genetics
  • Metabolism

Background:

  • Organ wasting is linked to metabolic changes during starvation and diseases like cancer.
  • The Yap1 oncogene ortholog, Yorkie, plays a role in cell proliferation.

Purpose of the Study:

  • To develop a Drosophila model for studying organ wasting.
  • To investigate the mechanisms by which gut overproliferation causes systemic organ wasting.
  • To understand how overproliferating tissues adapt to metabolic changes.

Main Methods:

  • Induction of Yorkie overproliferation in adult Drosophila intestinal stem cells.
  • Analysis of organ wasting phenotypes (ovary, fat body, muscle).
  • Measurement of systemic insulin/IGF signaling and ImpL2 expression.
  • Assessment of glycolytic enzyme and insulin/IGF pathway component expression in the gut.

Main Results:

  • Yorkie activation in gut stem cells induced ovary, fat body, and muscle wasting.
  • Organ wasting correlated with increased gut ImpL2 expression, reducing systemic insulin/IGF signaling.
  • Overproliferating gut tissues upregulated glycolytic enzymes and insulin/IGF pathway components.
  • This upregulation may allow the gut to evade the effects of ImpL2.

Conclusions:

  • Drosophila model effectively demonstrates organ wasting driven by gut overproliferation.
  • Systemic insulin/IGF signaling reduction is a key mechanism in Yorkie-induced organ wasting.
  • Overproliferating gut exhibits adaptive metabolic changes to counteract systemic signals.